all press releases

  • 11/08/18
    IRVING, Texas--(BUSINESS WIRE)--Suppliers interested in showcasing their innovative technology to decision makers from hospitals from across the country are encouraged to submit their application now to participate in the 2019 Vizient Innovative Technology Exchange. The event, which is part of Vizient’s Spring Connections Summit, will take place on Thursday, April 4, 2019, at the Aria in Las Vegas. The deadline to apply to participate in the Exchange is Friday, Nov. 30more...
  • 11/05/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient announces its support for the approval of UDENYCA™ (pegfilgrastim-cbqv), the second pegfilgrastim biosimilar approved by the Food and Drug Administration (FDA) and the first to be authorized by both the U.S. and the European Commission for patients with cancer receiving myelosuppressive chemotherapy. UDENYCA is the first drug from Coherus BioSciences, Inc. (NASDAQ: CHRS) to receive FDA or EC approvalmore...
  • 11/05/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. is disappointed that the Centers for Medicare and Medicaid Services (CMS) opted to finalize site-neutral payment reductions and the expansion of payment cuts related to the 340B Drug Pricing Program in the final 2019 Outpatient Prospective Payment System (OPPS) rule. The continuation of these damaging cuts will impact hospitals’ ability to maintain and expand access to care in rural and underservedmore...
  • 11/02/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient announces its strong support for the Department of Health and Human Services’ (HHS) proposed rule to implement a 340B Drug Pricing Program regulation that would refine calculations establishing the 340B ceiling price and apply penalties for drug manufacturers that knowingly overcharge hospitals for drugs purchased through the program. The proposed rule would move the effective date to Jan. 1, 2019more...
  • 11/02/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, the largest member-driven health care performance improvement company in the country and its subsidiary Provista, a leading supply chain partner for non-acute health care delivery organizations, urge CMS to reconsider its approach to the Medicare home infusion therapy benefit to recognize the full array of services needed for home infusion therapy services. Yesterday afternoon CMS finalized a verymore...
  • 10/30/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announces that Penn Medicine Princeton Health has joined the organization and will access the group purchasing portfolio as well as several analytics solutions such as Vizient Clinical Data Base and Resource ManagerTM and Vizient Savings ActualyzerTM. “We are very excited to welcome Penn Medicine Princeton Health to the Vizient membership. By aligning their cost-savings initiatives with ourmore...
  • 10/29/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announces 30 new, renewed or expanded member agreements with health care organizations in the second quarter of 2018. The new agreements, which include a range of academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers, demonstrate continued growth and high member retention for the company. “With anmore...
  • 10/22/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announces it has been ranked in the top 50 among healthcare suppliers/vendors in the Modern Healthcare 2018 Best Places to Work in Healthcare list. The complete list of this year’s winner rankings is available here. This is the second year Vizient has been recognized since the company’s integration in 2016. “It is an honor to again be recognized by Modern Healthcare as a Best Placesmore...
  • 10/17/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. has released findings from a new survey of over 90 member hospital and health system leaders across the country about how they are coping with the opioid crisis. Specifically, the survey looks at what changes hospitals are implementing, what is working and the challenges to manage resources effectively in the face of the opioid crisis. The survey’s findings demonstrate a clear effort bymore...
  • 10/10/18
    IRVING, Texas--(BUSINESS WIRE)--In the United States there are currently about 20 million veterans, many still struggling with the wounds of war long after they’ve returned to civilian life. To help address this challenge, Vizient has published, “Trends in Demographic Data Collection and Use in Healthcare: A Field Guide for Improving Care for Veterans.” The field guide focuses on the collection and use of veteran status while highlighting Lehighmore...